DANIEL NORDQUIST: Open Payments
NPI 1205390176 · MASHPEE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 26 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $83 · 2025 $1,033
Food & beverage: $1,033
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $559 |
| GENZYME CORPORATION | 9 | $320 |
| GlaxoSmithKline, LLC. | 3 | $87 |
| Genentech USA, Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $33 |
Products named: DUPIXENT, NUCALA, Xolair, TUDORZA PRESSAIR.
Industry payments across MA — which companies pay providers there.
